fitusiran 20 MG per 0.2 ML Injection
- RxCUI
- 2709452
- RxNorm name
- fitusiran 20 MG per 0.2 ML Injection
- Display name
- fitusiran 20 MG per 0.2 ML Injection
- Full name
- fitusiran 20 MG per 0.2 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Qfitlia | FITUSIRAN | Genzyme Corporation | 6dd2f8ac-6f90-4cbf-b197-97d74964135c | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 2709452 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6dd2f8ac-6f90-4cbf-b197-97d74964135c | fitusiran 20 MG per 0.2 ML Injection | SY | 6 | These highlights do not include all the information needed to use QFITLIA ® safely and effectively. See full prescribing information for QFITLIA. QFITLIA (fitusiran) injection, for subcutaneous use Initial U.S. Approval: 2025 | 20250916 |
| 6dd2f8ac-6f90-4cbf-b197-97d74964135c | 0.2 ML fitusiran 100 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use QFITLIA ® safely and effectively. See full prescribing information for QFITLIA. QFITLIA (fitusiran) injection, for subcutaneous use Initial U.S. Approval: 2025 | 20250916 |
| 6dd2f8ac-6f90-4cbf-b197-97d74964135c | fitusiran 20 MG in 0.2 ML Injection | PSN | 6 | These highlights do not include all the information needed to use QFITLIA ® safely and effectively. See full prescribing information for QFITLIA. QFITLIA (fitusiran) injection, for subcutaneous use Initial U.S. Approval: 2025 | 20250916 |